Terms: = Lung cancer AND CEACAM5, CEA
2636 results:
1. HBB as a Novel Biomarker for the Diagnosis and Monitoring of lung cancer Regulates Cell Proliferation via ERK1/2 Pathway.
Xu X; Cai H; Peng J; Liu H; Chu F
Technol Cancer Res Treat; 2024; 23():15330338241249032. PubMed ID: 38679728
[No Abstract] [Full Text] [Related]
2. Clinical effect of anlotinib in combination with docetaxel in treating advanced non-small cell lung cancer.
Weng G; Fang W; Lin Y; Chen L; Su W
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):212-216. PubMed ID: 38678603
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
[No Abstract] [Full Text] [Related]
4. Application Value of CYFRA21-1 Combined with NSE, cea, and SCC-Ag in lung cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell lung cancer.
Zhang X; Qin Y; Chen X; Xiong M; Shu S
Technol Cancer Res Treat; 2024; 23():15330338241240683. PubMed ID: 38613340
[No Abstract] [Full Text] [Related]
6. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
7. Highly sensitive "off-on" sensor based on MXene and magnetic microspheres for simultaneous detection of lung cancer biomarkers - Neuron specific enolase and carcinoembryonic antigen.
Yin C; Zhao X; Liu Z; Ma L; Sun P; He L; Huang H; Bai P
Talanta; 2024 Jul; 274():126022. PubMed ID: 38574538
[TBL] [Abstract] [Full Text] [Related]
8. Determination of Tumor Marker Screening for lung cancer Using ROC Curves.
Dou X; Lu J; Yu Y; Yi Y; Zhou L
Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
[TBL] [Abstract] [Full Text] [Related]
9. Standardized uptake value
Jin B; Wen X; Tian H; Guo H; Hao M; Wu J; Li X; Ren Y; Wang X; Ren X
Cancer Med; 2024 Apr; 13(7):e6961. PubMed ID: 38549459
[TBL] [Abstract] [Full Text] [Related]
10. Combined detection of serum IL-6 and cea contributes to the diagnosis of lung adenocarcinoma
Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
PeerJ; 2024; 12():e17141. PubMed ID: 38529301
[TBL] [Abstract] [Full Text] [Related]
11. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
12. Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer.
Wang Y; Ouyang S; Liu M; Si Q; Zhang X; Zhang X; Li J; Wang P; Ye H; Shi J; Song C; Wang K; Dai L
BMC Cancer; 2024 Mar; 24(1):283. PubMed ID: 38431566
[TBL] [Abstract] [Full Text] [Related]
13. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation.
Liu J; Bian T; She B; Liu L; Sun H; Zhang Q; Zhu J; Zhang J; Liu Y
BMC Cancer; 2024 Mar; 24(1):282. PubMed ID: 38429660
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract] [Full Text] [Related]
15. CT-guided radioactive
Song M; Zhou X; Hou R; Sigdel M; Liu Y; Zhang C; Xu K; Han X; Jiao D
BMC Cancer; 2024 Feb; 24(1):265. PubMed ID: 38403626
[TBL] [Abstract] [Full Text] [Related]
16. Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Akita T; Ariyasu R; Kakuto S; Miyadera K; Kiritani A; Tsugitomi R; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Tasaka S; Nishio M
Thorac Cancer; 2024 Apr; 15(10):788-796. PubMed ID: 38400801
[TBL] [Abstract] [Full Text] [Related]
17. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
18. Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.
Lee J; Lee DH; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2024 Mar; 39(2):318-326. PubMed ID: 38351680
[TBL] [Abstract] [Full Text] [Related]
19. Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.
Thamrongjirapat T; Muntham D; Incharoen P; Trachu N; Sae-Lim P; Sarachai N; Khiewngam K; Monnamo N; Kantathut N; Ngodngamthaweesuk M; Ativitavas T; Chansriwong P; Nitiwarangkul C; Ruangkanchanasetr R; Kositwattanarerk A; Sirachainan E; Dejthevaporn T; Reungwetwattana T
BMC Cancer; 2024 Feb; 24(1):200. PubMed ID: 38347487
[TBL] [Abstract] [Full Text] [Related]
20. Correlation Analysis of KCNQ1 Gene Polymorphism with Blood Indexes and Prognosis of Non-Small Cell lung cancer.
Xie G; Yang Y; Zeng W; Liu Y; Gui B
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345992
[TBL] [Abstract] [Full Text] [Related]
[Next]
